Publication Name	World Journal of Gastroenterology
Manuscript ID	5992
Country	Japan

Received	2013-09-29 15:38
Peer-Review Started	2013-09-30 13:32
To Make the First Decision	2013-12-04 08:58
Return for Revision	2013-12-04 19:19
Revised	2013-12-20 23:35
Second Decision	2014-01-08 18:09
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-01-08 18:43
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-03-10 15:36
Publish the Manuscript Online	2014-03-27 12:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Role of stereotactic body radiation therapy for hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Naoko Sanuki, Atsuya Takeda and Etsuo Kunieda
Funding Agency and Grant Number
Corresponding Author	Naoko Sanuki, MD, Radiation Oncology Center, Ofuna Chuo Hospital, 6-2-24, Ofuna, Kamakura, Kanagawa 247-0056, Japan. nao5-tky@umin.org
Key Words	Hepatocellular carcinoma; Liver cirrhosis; Liver neoplasms; Radiation therapy; Stereotactic body radiation therapy
Core Tip	The integration of new technologies has raised an interest in radiotherapy for hepatocellular carcinoma (HCC), with literature evolving to support its efficacy. These advances, particularly stereotactic body radiation therapy (SBRT), have been critical in improving local control or potential cure in liver lesions not amenable to first-line surgical resection or radiofrequency ablation. Active investigation of SBRT has recently started, yielding promising local control rates. However, information on optimal treatment indications, doses, and methods remains limited. In HCC, significant differences in patient characteristics and treatment availability exist by country. Further studies are required to validate and maximize the efficacy of SBRT.
Publish Date	2014-03-27 12:04
Citation	Sanuki N, Takeda A, Kunieda E. Role of stereotactic body radiation therapy for hepatocellular carcinoma. World J Gastroenterol 2014; 20(12): 3100-3111
URL	http://www.wjgnet.com/1007-9327/full/v20/i12/3100.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i12.3100

Full Article (PDF)	WJG-20-3100.pdf
Full Article (Word)	WJG-20-3100.doc
Manuscript File	5992-Review.docx
Answering Reviewers	5992-Answering reviewers.pdf
Copyright License Agreement	5992-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5992-Language certificate.pdf
Peer-review Report	5992-Peer review(s).pdf
Scientific Editor Work List	5992-Scientific editor work list.doc